glp-1 vomiting and diarrhea RAs, GI Side Effects: European 2022 Guideline Summary The GLP-1 Prescribing Cheat Sheet
Description
Many insurance plans do cover GLP-1 medications for the treatment of type 2 diabetes and obesity, but coverage may be limited for certain medications or patient populations

Are other dual-agonists in development as effective, and what factors (e.g., tolerability profile) may allow for competitive differentiation

Note: If you have a family history of a certain type of thyroid cancer (medullary thyroid carcinoma, or MCT), you should not use GLP-1 medications

In mice, genetic deletion or pharmacologic inhibition of DPP4 is able to increase the homing of CXCR4+ EPC at sites of myocardial damage, resulting in a reduced cardiac remodeling and improved heart function and survival (200)

Secondary endpoints Secondary outcomes also demonstrated favorable effects of GLP-1 RAs